Discovery of common and rare genetic risk variants for colorectal cancer
2018 · Nature Genetics · 596 citations
https://doi.org/10.1038/s41588-018-0286-6
G
Gemma Ibáñez‐Sanz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
1.3K
Citations
14
h-index
19
i10-index
Gemma Ibáñez‐Sanz is an academic researcher from Bellvitge University Hospital. The author has contributed to research in topics: Colorectal Cancer Screening and Detection & Genetic factors in colorectal cancer & Gastric Cancer Management and Outcomes. The author has an h-index of 14, co-authored 55 publications.
ORCID: 0000-0001-6071-7343Papers by this author
worksIdentifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study
2020 · Scientific Reports · 60 citations
https://doi.org/10.1038/s41598-020-76361-2
Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study
2018 · Scientific Reports · 22 citations
https://doi.org/10.1038/s41598-018-20349-6
Additional file 4 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.16946435
Additional file 3 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.16946432
Additional file 1 of Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.16946423
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat